• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.49 Up 0.05(1.13%) Apr 24, 4:00PM EDT
    |After Hours : 4.53 Up 0.04 (0.89%) Apr 24, 4:13PM EDT
    Add to Portfolio
    Prev Close:4.44
    Open:4.41
    Bid:4.52 x 200
    Ask:4.62 x 1000
    1y Target Est:7.42
    Beta:-4.46
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.35 - 4.54
    52wk Range:3.26 - 7.22
    Volume:1,539,205
    Avg Vol (3m):4,377,680
    Market Cap:1.08B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 1.13%1.08B
    GSKUp 0.60%112.07B
    OREXDown 1.08%910.64M
    RHHBYDown 0.83%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.00
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback